Google
CUBT — CURATIVE BIOTECHNOLOGY INC (Healthcare >> Biotechnology)
CUBT FAQ
What is CUBT's ROE?
CURATIVE BIOTECHNOLOGY INC reports a Return on Equity (ROE) of 41.84%.
What is CUBT's dividend yield?
CURATIVE BIOTECHNOLOGY INC offers a dividend yield of 0.00%.
What is CUBT's Deepscope Quality Score?
Deepscope rates CUBT's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CUBT?
Deepscope's AI Timing Score for CUBT is 5 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CUBT belong to?
CURATIVE BIOTECHNOLOGY INC is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange.
|
USD 1.54
Price
0.02
(1.32%)
Day Change
|
|
|---|
CUBT, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.54 |
| PBV / Sector |
-1.86 / 4.79
|
| Earning Per Share | -0.35 |
| PE / Sector |
N/A / 18.05
|
| PEG or PE/Growth / Sector |
N/A / 0.62
|
| Average 1M Daily Value |
1520.585180000000
|
| Average 1W Daily Value |
435.112000000000
|
| Timing Factors |
|
57% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-12 09:43:23 |
| Symbol | CUBT |
| Name | CURATIVE BIOTECHNOLOGY INC |
| Sector | Healthcare >> Biotechnology |
| Market | NYSE MKT |
| Listed Shares | 7.66 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 11.72 / 9,010.81 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 3801 PGA Blvd, Palm Beach Gardens, FL, United States, 33410
Phone: 561 907 8990
Website: https://curativebiotech.com
Sector: Healthcare >> Biotechnology
Description: Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies; and CUBT906, a fully humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine; and development agreement with the University of Pennsylvania School of Veterinary Medicine for the development of a metformin-based ophthalmic formulation. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
